First Pharmacogenomics Study on COVID-19 Vaccine Reactions
Scientists surveyed more than 17,000 participants from the Helix DNA Discovery Project and Healthy Nevada Project, who had their DNA previously sequenced with the Helix Exome+ assay, and asked respondents about their specific reactions to the COVID-19 vaccine, in order to perform a genome wide association study (GWAS).
The study identified that participants with the HLA-A*03:01 allele who received the Pfizer-BioNTech (Pfizer) vaccine are approximately twice as likely to have severe or extreme difficulties after receiving the vaccine (defined as reactions that would severely interfere with daily routine like fever and chills), than those without the allele. In contrast, the signal was very weak for those receiving the Moderna vaccine and did not approach genome-wide significance, despite a similar sample size. This held true across age groups, sex, and whether the person had a personal history of COVID-19 prior to the vaccination.
Learn more about how to integrate genomics into everyday patient care, as well as, the pioneering research that health systems across the US are partnering with Helix to publish here.
Helix is the leading population genomics and viral surveillance company operating at the intersection of clinical care, research, and data analytics.
In September 2020, researchers in the UK first detected a SARS-CoV-2 variant that was more transmissible and deadly than the original strain. Later designated as the Alpha variant by the World Health Organization (WHO), the surge in cases caused by…
Health systems in the U.S. have always played an important role in supporting public health, but the past two years have required them to step into a more expansive role. With the unexpected demands of an unfolding pandemic, health systems…
Viral surveillance has once more proven its usefulness as researchers in South Africa alerted the world to the growing prevalence of Omicron—a new SARS-CoV-2 variant which, on November 26, was designated by the World Health Organization (WHO) as a Variant…
All rights reserved. Helix, the Helix logo, Exome+, and Sequence Once, Query Often are trademarks of Helix OpCo, LLC. All other trademarks referenced herein are the property of their respective owners.